CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

BACKGROUND: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory reference intervals derived from other populat...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Public Library of Science 2009

Ижил төстэй зүйлс

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.
-н: Price, M, зэрэг
Хэвлэсэн: (2011)

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
-н: Stevens, W, зэрэг
Хэвлэсэн: (2008)

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
-н: Price, M, зэрэг
Хэвлэсэн: (2012)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
-н: Ngongo BP, зэрэг
Хэвлэсэн: (2012-09-01)

Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing.
-н: Anzala, O, зэрэг
Хэвлэсэн: (2008)

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
-н: Ming M. Zhang, зэрэг
Хэвлэсэн: (2023-09-01)

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
-н: Wallis, C, зэрэг
Хэвлэсэн: (2010)

Time to switch from CLSI to EUCAST? a Southeast Asian perspective
-н: Cusack, T, зэрэг
Хэвлэсэн: (2019)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
-н: Cusack, T-P, зэрэг
Хэвлэсэн: (2019)

Eﬀect of Diﬀerences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
-н: L. A. Kornoukhova, зэрэг
Хэвлэсэн: (2021-10-01)

Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection
-н: Price, M, зэрэг
Хэвлэсэн: (2019)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions.
-н: Li, X, зэрэг
Хэвлэсэн: (2014)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
-н: Li, X, зэрэг
Хэвлэсэн: (2014)

Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda.
-н: Eugene Ruzagira, зэрэг
Хэвлэсэн: (2011-01-01)

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.
-н: Nyiro, J, зэрэг
Хэвлэсэн: (2011)

Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
-н: Ali Korhan Sığ
Хэвлэсэн: (2022-01-01)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
-н: Erin Hitchingham, зэрэг
Хэвлэсэн: (2023-06-01)

CLSI Guided Reference Interval Limits for Cancer Biomarkers for Adults and Geriatrics
-н: Richard M. Gitimu, зэрэг
Хэвлэсэн: (2022-06-01)

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.
-н: Tang, J, зэрэг
Хэвлэсэн: (2011)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
-н: Amornkul, P, зэрэг
Хэвлэсэн: (2013)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
-н: Asiki G, зэрэг
Хэвлэсэн: (2009-10-01)

HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?
-н: Prentice, H, зэрэг
Хэвлэсэн: (2013)

Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
-н: Prentice, H, зэрэг
Хэвлэсэн: (2013)

Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards
-н: Richard A. Festa, зэрэг
Хэвлэсэн: (2025-02-01)

Novedades CLSI y EUCAST 2024 sobre detección y uso de antibióticos
-н: Diego Herrera, зэрэг
Хэвлэсэн: (2024-08-01)

Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing
-н: Yamuna Devi Bakthavatchalam, зэрэг
Хэвлэсэн: (2017-08-01)

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research.
-н: Chantler, T, зэрэг
Хэвлэсэн: (2014)

International health research monitoring: Exploring a scientific and a cooperative approach using participatory action research
-н: Chantler, T, зэрэг
Хэвлэсэн: (2014)

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
-н: Karita, E, зэрэг
Хэвлэсэн: (2007)

Влияние расхождений критериев CLSI и EUCAST на интерпретацию чувствительности Enterobacteriaceae к карбапенемам
Хэвлэсэн: (2021-10-01)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
-н: Fast P, зэрэг
Хэвлэсэн: (2009-10-01)

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
-н: Jaoko, W, зэрэг
Хэвлэсэн: (2008)

Uptake of Revised CLSI Breakpoints and Potential Impact among Hospitals Reporting to The NHSN AR Option, 2022
-н: Allan Nkwata, зэрэг
Хэвлэсэн: (2024-07-01)

A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations
-н: Agila Kumari Pragasam, зэрэг
Хэвлэсэн: (2016-07-01)

Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines
-н: Katarzyna Haynesworth, зэрэг
Хэвлэсэн: (2024-11-01)

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
-н: Boaz, M, зэрэг
Хэвлэсэн: (2009)

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
-н: Mutua, G, зэрэг
Хэвлэсэн: (2012)

CLSY docking to Pol IV requires a conserved domain critical for small RNA biogenesis and transposon silencing
-н: Luisa Felgines, зэрэг
Хэвлэсэн: (2024-11-01)

Crystal structure of 1,1,2,2-tetra-tert-butyl-1,2-dichlorodisilane,[(C4H9)2ClSi]2
-н: Peters K., зэрэг
Хэвлэсэн: (1998-04-01)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
-н: Bayingana R, зэрэг
Хэвлэсэн: (2012-09-01)